Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (541-550 of 666) with videos related to

Pageof 67
Sort By:
Plos One|August 21, 2018
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Plos One|September 14, 2018
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
BMC Nephrology|June 12, 2016
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohortMartin Busch, Jennifer Nadal, Matthias Schmid, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 1, 2021
Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort StudyKarin Windahl, , Gerd Faxén Irving, et al.
Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.
Molecular Genetics and Metabolism|May 26, 2023
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry communityChristoph Wanner, Alberto Ortiz, William R Wilcox, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 19, 2015
Calculating the Rate of Senescence From Mortality Data: An Analysis of Data From the ERA-EDTA RegistryJacob J E Koopman, Maarten P Rozing, Anneke Kramer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 14, 2023
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-upEsther N M de Rooij, Johan W de Fijter, Saskia Le Cessie, et al.
Diabetes Care|May 24, 2020
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized TrialVlado Perkovic, Robert Toto, Mark E Cooper, et al.
Clinical Kidney Journal|November 2, 2023
Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease-prospective data from the German Chronic Kidney Disease cohortJohannes Ruhe, Jennifer Nadal, Barbara Bärthlein, et al.
Pageof 67

Showing results (541-550 of 666) with videos related to

Sort By:
Pageof 67
Plos One|August 21, 2018
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Plos One|September 14, 2018
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
BMC Nephrology|June 12, 2016
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohortMartin Busch, Jennifer Nadal, Matthias Schmid, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 1, 2021
Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort StudyKarin Windahl, , Gerd Faxén Irving, et al.
Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.
Molecular Genetics and Metabolism|May 26, 2023
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry communityChristoph Wanner, Alberto Ortiz, William R Wilcox, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 19, 2015
Calculating the Rate of Senescence From Mortality Data: An Analysis of Data From the ERA-EDTA RegistryJacob J E Koopman, Maarten P Rozing, Anneke Kramer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 14, 2023
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-upEsther N M de Rooij, Johan W de Fijter, Saskia Le Cessie, et al.
Diabetes Care|May 24, 2020
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized TrialVlado Perkovic, Robert Toto, Mark E Cooper, et al.
Clinical Kidney Journal|November 2, 2023
Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease-prospective data from the German Chronic Kidney Disease cohortJohannes Ruhe, Jennifer Nadal, Barbara Bärthlein, et al.
Pageof 67